Skip to Accessibility Menu Skip to Login Skip to Content Skip to Footer

Forums

Read conversations, start a discussion, and connect with others about plaque psoriasis.

Will You Take Our 7th Annual Psoriasis In America Survey?

About 125 million people suffer from psoriasis, making up 2-3% of the global population. To better understand the experiences and realities of psoriasis, we are fielding our 7th annual Psoriasis...

My Effective Treatment for psoriasis

Psoriasis has been an issue for me for over 50 years. For the vast of those tears I had no idea what it was. It manifest itself as very dry...

New medication anxiety

A year ago I was on a biologic that put me in remission for my psoriasis, psoriatic arthritis and leukocytic colitis. My quality of life was excellent and I became...

Psoriasis in the ears

Ok so to begin this I don't know what it is that's bothering my ears, I've had ear infection after ear infection since 2017 which I had chalked up to...

Remission

I am seven or eight years in remission now. I have had very small patches since but nothing like I used to have. I had about 85% coverage for five...

Featured

new diagnosis, treatment question

Hello, I just recently received a diagnosis of psoriatic arthritis, 2 weeks ago, so this is all new to me. Well, reading others' stories, finding out I'm not alone, and...

Otezla (Apremilast) - changes in one week !

hi fellow amazing psoriasis friends. I have just started taking Otezla (Apremilast) which was recommended by the dermatologist for a week now and oh boy I am seeing some changes...

I went to the Dermatologists, prescribed Apremilast

Hi All Just back from the Dermatologist and was prescribed Apremilast. It inhibits the activity of phosphodiesterase type-4 (PDE4) which results in suppression of pro-inflammatory mediator synthesis Whilst there, I...

Options for our younger 'members':

Dewi here: Glacial progress: In December 2021, the U.S. Food and Drug Administration (FDA) approved Cosentyx® (secukinumab) for the treatment of active psoriatic arthritis (PsA) in patients 2 years and...

Latest Biologic - just in case:

Dewi here: Not sure if you've seen this, so just in case: On January 21, 2022 the U.S. Food and Drug Administration (FDA) approved SKYRIZI® (risankizumab-rzaa), an interleukin-23 inhibitor, for...

Categories

Select a category to find topics that interest you.